SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

BP Prudhoe Bay Royalty Trust – ‘10QSB’ for 3/31/98

As of:  Friday, 5/15/98   ·   For:  3/31/98   ·   Accession #:  950115-98-991   ·   File #:  1-10243   ·   Correction:  This Filing was Deleted by the SEC on 5/29/98. ®

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 5/15/98  BP Prudhoe Bay Royalty Trust      10QSB       3/31/98    2:15K                                    Global Fin’l Press/FA

Quarterly Report — Small Business   —   Form 10-QSB
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10QSB       Quarterly Report                                       8     29K 
 2: EX-27       Financial Data Schedule                                1      8K 


10QSB   —   Quarterly Report
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
7Item 5. Other Information On April 24, 1998, the Registrant announced the appointment of Randall Rueb as the Registrant's Chief Financial Officer
10QSB1st Page of 8TOCTopPreviousNextBottomJust 1st
 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-QSB QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended March 31, 1998 Commission File No. 0-23016 HealthRite, Inc. -------------------------------------------------------------------------------- (Exact name of small business issuer in its charter) Delaware 13-3714405 ----------------------------------- ----------------------------------------- (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 11445 Cronhill Drive, Owings Mills, MD 21117 -------------------------------------------- (Address of principal offices & Zip Code) Registrant's telephone number, including Area Code: (410) 581-8042 -------------- Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes |X| No | | Number of shares outstanding of Registrant's Common Stock, as of May 9, 1998: 4,400,198 shares Transitional Small Business Disclosure Format (check one). Yes | | No |X|
10QSB2nd Page of 8TOC1stPreviousNextBottomJust 2nd
HealthRite, Inc. Index Part I Financial Information: Condensed Consolidated Balance Sheet - March 31, 1998 (unaudited) and December 31, 1997 3 Condensed Consolidated Statement of Operations - Three Months Ended March 31, 1998 and 1997 (unaudited) 4 Condensed Consolidated Statement of Cash Flows - Three Months Ended March 31, 1998 and 1997 (unaudited) 5 Notes to Condensed Consolidated Financial Statements 6 Management Discussion and Analysis of Financial Condition and Results of Operations 7 Part II Other Information 8 Signature Page 9 2
10QSB3rd Page of 8TOC1stPreviousNextBottomJust 3rd
HealthRite, Inc. Condensed Consolidated Balance Sheet March 31, 1998 December 31, 1997 (Unaudited) [Enlarge/Download Table] Three Months Ended March 31, March 31, 1998 December 31, 1997 (Unaudited) -------------- ----------------- ASSETS Current assets: Cash ............................................................................. $ 397,000 $ 255,000 Accounts receivable, net of allowance ........................................... 1,423,000 1,112,000 Merchandise inventory ............................................................ 2,158,000 2,397,000 Prepaid expenses and other current assets ........................................ 550,000 266,000 ----------- ----------- Total Current Assets ............................................................. 4,528,000 4,030,000 Property, plant and equipment - net .................................................. 2,832,000 2,674,000 Other assets ......................................................................... 139,000 240,000 ----------- ----------- TOTAL ASSETS ................................................................ $ 7,499,000 $ 6,944,000 =========== =========== LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities: Current maturities of long-term obligations ...................................... $ 603,000 $ 333,000 Accounts payable and accrued expenses ............................................ 2,294,000 1,623,000 ----------- ----------- Total Current Liabilities ........................................................ 2,897,000 1,956,000 Long-term obligations and capital leases ............................................. 2,516,000 2,198,000 ----------- ----------- Total Liabilities ........................................................... 5,413,000 4,154,000 Commitments and Contingencies Redeemable convertible 8% preferred stock; par value $.001; 2,000,000 authorized; 432,500 issued and outstanding ................................................... 780,000 774,000 ----------- ----------- Stockholders' Equity Common stock; par value $.001 per share; 10,000,000 authorized; 4,400,198 issued at March 31, 1998 and 4,400,198 issued at December 31, 1997 ........................................ 4,000 4,000 Additional paid-in capital ............................................. 7,141,000 7,141,000 Accumulated deficit ............................................................. (5,839,000) (5,129,000) ----------- ----------- Total Equity ................................................................ 1,306,000 2,016,000 ----------- ----------- TOTAL LIABILITIES & STOCKHOLDER'S EQUITY ........................................ $ 7,499,000 $ 6,944,000 =========== =========== 3
10QSB4th Page of 8TOC1stPreviousNextBottomJust 4th
HealthRite, Inc. Condensed Consolidated Statement of Operations Three Months Ended March 31, 1998 1997 ---- ---- Revenue .................................... $2,941,000 $4,271,000 Cost of sales, including warehousing distribution, and occupancy ............ 1,846,000 2,616,000 ---------- ---------- Gross Profit ............................... 1,095,000 1,655,000 Selling, general, and administration ....... 1,724,000 1,778,000 Cost of Consolidation Plan ---------- ---------- Loss from operations ....................... (629,000) (123,000) Other Income/(Expenses) Interest, net .......................... (57,000) (70,000) ---------- ---------- Loss from operations before provision for income taxes ........ (686,000) (193,000) Provision (Benefit) for income taxes ....... 0 (23,000) ---------- ---------- Loss from continuing operations ............ (686,000) (170,000) ---------- ---------- Net Loss ................................... (686,000) (170,000) ========== ========== Less: Stock dividend on preferred stock..... (18,000) (17,000) Accretion of preferred stock ......... (6,000) (6,000) Net Loss attributable to common shareholders $ (710,000) $ (193,000) ---------- ---------- Net Loss per share (basic and diluted) ..... $ (0.16) $ (0.04) ========== ========== Weighted average shares outstanding ........ 4,400,000 4,300,000 4
10QSB5th Page of 8TOC1stPreviousNextBottomJust 5th
HealthRite, Inc. Condensed Consolidated Statement of Cash Flows [Enlarge/Download Table] Three Months Ended March 31, 1998 1997 Cash Flow from Operating Activities: Net Loss ........................................... $ (710,000) $ (193,000) Depreciation & amortization ................... 114,000 184,000 Deferred tax asset ............................ 0 (32,000) Changes in assets and liabilities: Changes in assets and liabilities: (Increase)/decrease in accounts receivable .... (311,000) (205,000) (Increase)/decrease in inventory .............. 239,000 (158,000) (Increase)/decrease in prepaid expenses & other current assets .......................... (284,000) (152,000) (Increase)/decrease in plant equipment ........ (247,000) 0 (Increase)/decrease in A/P and accrued expenses 670,000 704,000 ----------- ----------- Net Cash provided by Operating Activities .......... (529,000) 148,000 ----------- ----------- Cash Flow from Investing Activities: Purchase of equipment .............................. (24,000) (79,000) Increase/(decrease) in other assets ................ 107,000 (16,000) ----------- ----------- Total Cash Flow from Investing Activities .......... 83,000 (95,000) ----------- ----------- Cash Flow from Financing Activities: Proceeds from debt ................................. 1,262,000 111,000 Payment of debt .................................... (674,000) (72,000) ----------- ----------- Net Cash provided by Financing Activities: ............. 588,000 39,000 ----------- ----------- NET INCREASE/(DECREASE) IN CASH ........................ 142,000 92,000 Cash and cash equivalents at beginning of period ....... 255,000 286,000 ----------- ----------- Cash and cash equivalents at end of period ............. $ 397,000 $ 378,000 =========== =========== Supplemental disclosure of cash flow information: Cash paid during the period for: Interest ...................................... 63,000 70,000 Income Taxes .................................. 0 6,000 ----------- ----------- Total ....................................... $ 63,000 $ 76,000 5
10QSB6th Page of 8TOC1stPreviousNextBottomJust 6th
HealthRite, Inc. Notes to Condensed Consolidated Financial Statements 1. Basis of Presentation The information contained herein with respect to the three month periods ended March 31, 1998 and 1997 has not been audited but was prepared in conformity with generally accepted accounting principles for interim financial information and with instructions for Form 10-QSB and Item 310(b) of Regulation S-B. Accordingly, the combined condensed financial statements do not include information and footnotes required by generally accepted accounting principles for financial statements. Included are the adjustments, which in the opinion of management are necessary for a fair presentation of the financial information for the three month periods ended March 31, 1998 and 1997. The results are not necessarily indicative of results to be expected for the year. 6 HealthRite, Inc. Management Discussion and Analysis of Financial Condition and Results of Operations General Three Months Ended March 31, 1998 and March 31, 1997. Revenues decreased $1,330,000 or 31% under the comparative period. The decrease was attributable to selling the retail stores of the Vitamin Specialties operation in June 1997 and the decrease in Nautilus sales. Congruently, cost of sales, including warehousing, distribution, and occupancy decreased $770,000 or 29%. The percentage of cost of sales to revenues increased 1.5%. Also in conjunction with the revenue decrease, selling, general and administrative expenses decreased $54,000. As a percentage of revenues, selling, general and administrative expenses increased by 17% between year to date March 1997 and year to date March 1998. The increase was fundamentally attributable to the increased advertising expense of $470,000 arranged by previous management and recognized in the 1st Quarter. Interest expense was $63,000 in the 1st Quarter of 1998 as compared to $70,000 in the same period of 1997. The difference was attributable to better interest rates on outstanding borrowings. 7
10QSB7th Page of 8TOC1stPreviousNextBottomJust 7th
PART II- Other Information Seasonality The Registrant believes that its business is not subject to significant seasonality. Liquidity and Capital Resources In October 1997, U.S. Bank, formerly the First Bank, Montana (with a U.S. Department of Agriculture guarantee) provided a $4,500,000 financing package, and Lake County Community Development Corporation (through a CDBG grant) provided an additional $450,000 financing package for the expansion of plant and equipment and working capital in return for the Registrant's pledge to expand operations and increase the employee count in Arlee, Montana. Funding of these loans began in 1997. Terms of the loan specify that plant and equipment additions be completed by September 30, 1998. The Registrant has assigned the Nautilus distribution rights for network marketing to Worldwide Universal Health, Inc., a network marketing company. HealthRite will receive over $100,000 from Worldwide Universal Health, Inc. for these rights and inventory. In December 1997 the Registrant's subsidiary, Jason Pharmaceuticals, Inc., entered into a loan agreement with Century Credit Corporation to provide working capital. A term loan of $260,000 and a revolving credit line with advances based on percentages of accounts receivable and raw materials inventory were obtained. The total of the revolving credit and term loan outstanding was limited to a total of $1,000,000. At March 31, 1998 $600,000 was available, of which $341,000 had been drawn. The term loan balance was $244,000. The Company had working capital of $1,631,000 on March 31, 1998 compared with $2,074,000 at December 31, 1997. The $443,000 decrease reflects the recording in the 1st Quarter of 1998 of $470,000 in advertising debt and inventory write-offs which were offset by increases in current assets. Inflation To date, inflation has not had a material effect on the Registrant's business. Item 5. Other Information On April 24, 1998, the Registrant announced the appointment of Randall Rueb as the Registrant's Chief Financial Officer. 8
10QSBLast Page of 8TOC1stPreviousNextBottomJust 8th
Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized. HealthRite Inc. (Registrant) ----------------------------- Bradley T. MacDonald Chairman and CEO ----------------------------- Randall Rueb Chief Financial Officer 9

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘10QSB’ Filing    Date First  Last      Other Filings
9/30/98710-Q
Deleted on:5/29/98
Filed on:5/15/9810-Q
5/9/981
4/24/987
For Period End:3/31/981710-Q
12/31/973710-K405
3/31/972610-Q
 List all Filings 
Top
Filing Submission 0000950115-98-000991   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 3:45:23.1am ET